- 期刊
- OpenAccess
Contrast-Induced Encephalopathy in Patients with End-Stage Renal Disease: A Case Report and Literature Review
摘要
Patients with end-stage renal disease (ESRD) have complicated comorbidities and increased requirements for interventions and enhanced imaging. Currently, the use of a contrast agent is relatively safe, but it still causes several complications such as anaphylactic reactions, nephropathy, or encephalopathy. Here, we report the case of a patient who developed contrast-induced encephalopathy (CIE) with the presentation of sudden onset of conscious disturbance after undergoing computed tomography angiography and percutaneous transluminal angiography (PTA). His consciousness completely recovered within 2 days after 2 hemodialysis (HD) sessions. CIE is a rare and unexpected complication that might be associated with hyperosmolarity and chemotoxicity of contrast agents, causing damage of blood-brain barrier and neuronal excitability. The effect of CIE appears to be transient and reversible in dialysis-dependent patients. Physicians should be cautious regarding the conscious status of dialysis-dependent patients after contrast exposure in imaging studies and provide appropriate management.
延伸閱讀
- Choy, T. K., Ma, C. J., Huang, C. W., Chen, F. M., Chuang, C. H., Chan, H. M., Huang, C. J., & Wang, J. Y. (2015). The Clinical Outcomes of Surgical Resection for Primary Colorectal Cancer Patients with End Stage Renal Disease. 中華民國大腸直腸外科醫學會雜誌, 26(1), 8-13. https://doi.org/10.6312/SCRSTW.2015.26(1).10323
- FU, Y. T., Chang, C. L., Wang, J., Yang, T. H., Chang, S. Y., & Ma, C. P. (1991). Renal Calcified Pseudocyst with Extramedullary Hematopoiesis - A Case Report and Literature Review. 中華民國泌尿科醫學會雜誌, 2(4), 648-651. https://doi.org/10.7024/JUAROC.199112.0648
- 林威任、宋俊明、張育誌、吳安邦（2019）。Erythropoiesis-Stimulating Agent Resistance in End-Stage Renal Disease Patients: The Brief Review。腎臟與透析，31(4)，175-179。https://doi.org/10.6340/KD.201912_31(4).0004
- Chen, K. H., Hsu, H. C., Lin, K. Y., Shih, S. R., & Su, J. J. (2020). Abiraterone-induced Posterior Reversible Encephalopathy Syndrome in a Patient with Metastatic Prostate Cancer: A Case Report and Literature Review. Formosan Journal of Endocrinology and Metabolism, (), 1-7. https://doi.org/10.6856/FJEM.202212/PP.0006
- Chen, K. H., Hsu, H. C., Lin, K. Y., Shih, S. R., & Su, J. J. (2022). Abiraterone-induced Posterior Reversible Encephalopathy Syndrome in a Patient with Metastatic Prostate Cancer: A Case Report and Literature Review. Formosan Journal of Endocrinology and Metabolism, 13(2), 102-108. https://doi.org/10.6856/FJEM.202212_13(2).0014